Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 3 1

Status

Completed 5

Sponsor Class

INDUSTRY 5

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 5Sarcoma 4Lymphoid 2Gynecologic 2Thoracic 1Other solid neoplasm 1Other hematologic neoplasm 1Myeloid 1Genitourinary 1Classical hematology 1CNS 1Breast 1

Conditions

Pancreatic Neoplasms 2Liver Neoplasms 2Carcinoma, Hepatocellular 2Stomach Neoplasms 1Gallbladder Neoplasms 1Esophageal Neoplasms 1Bile Duct Neoplasms 1Adenocarcinoma Of Esophagus 1

Interventions

Fluorouracil 616Oxaliplatin 579Gemcitabine 492Capecitabine 445Leucovorin 427Irinotecan 390Bevacizumab 330Cisplatin 320Radiotherapy 245Cetuximab 215Sorafenib 167pembrolizumab 152Docetaxel 150Paclitaxel 140Nivolumab 128Albumin-Bound Paclitaxel 108130-nm albumin-bound paclitaxel 108Folfox protocol 101Panitumumab 95Erlotinib Hydrochloride 95Surgical Procedures, Operative 86regorafenib 84S 1 (combination) 81Drug Therapy 80Radiation 69Carboplatin 65Neoadjuvant Therapy 64Colonoscopy 64Radiosurgery 63Surveys and Questionnaires 60

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Completed × exatecan × Gastrointestinal × Clear all
NCT00003951 2012-05-16

DX-8951f in Treating Patients With Metastatic Cancer of the Pancreas

Daiichi Sankyo

Phase 2 Completed
37 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT00004108 2012-05-16

DX-8951f in Treating Patients With Liver Cancer

Daiichi Sankyo

Phase 2 Completed
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT00005938 2012-05-16

DX-8951f in Treating Patients With Biliary Cancer

Daiichi Sankyo

Phase 2 Completed
Gastrointestinal

Bile Duct Neoplasms, Gallbladder Neoplasms, Carcinoma, Hepatocellular, Liver Neoplasms

NCT00017212 2012-05-16

DX-8951f in Treating Patients With Metastatic Stomach Cancer

Daiichi Sankyo

Phase 2 Completed
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Neoplasms, Stomach Neoplasms

NCT00023972 2012-05-16

Gemcitabine With or Without Exatecan Mesylate in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

Daiichi Sankyo

Phase 3 Completed
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡